Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Epigenetic regulation
Klein, Christopher J. , Benarroch, Eduardo E. , Klein, Christopher J

Neurology | April 24, 2014 | Volume: 82 | Issue: 20 | Pages: 1833-1840

10.1212/wnl.0000000000000440 | PMID 24759839 Get It

DPAGT1 myasthenia and myopathy
Selcen, Duygu , Shen, Xin‐Ming , Brengman, Joan M., Stans, Anthony A. , Wieben, Eric D. , Engel, Andrew G. , Brengman, Joan, Wieben, Eric, Li, Ying

Neurology | April 24, 2014 | Volume: 82 | Issue: 20 | Pages: 1822-1830

10.1212/wnl.0000000000000435 | PMID 24759841 Get It

Application of Induced Pluripotent Stem Cells in Liver Diseases
Yu, Yue , Wang, Xuehao , Nyberg, Scott L.

Cell Medicine | April 24, 2014 | Volume: 7 | Issue: 1 | Pages: 1-13

10.3727/215517914x680056 | PMID 26858888 Get It

Tens of millions of patients are affected by liver disease worldwide. Many of these patients can benefit from therapy involving hepatocyte transplantation. Liver transplantation is presently the only proven treatment for many medically refractory liver diseases including end-stage liver failure and inherited metabolic liver disease. However, the shortage in transplantable livers prevents over 40% of listed patients per year from receiving a liver transplant; many of these patients die before receiving an organ offer or become too sick to transplant. Therefore, new therapies are needed to supplement whole-organ liver transplantation and reduce mortality on waiting lists worldwide. Furthermore, the remarkable regenerative capacity of hepatocytes in vivo is exemplified by the increasing number of innovative cell-based therapies and animal models of human liver disorders. Induced pluripotent stem cells (iPSCs) have similar properties to those of embryonic stem cells (ESCs) but bypass the ethical concerns of embryo destruction. Therefore, generation of hepatocyte-like cells (HLCs) using iPSC technology may be beneficial for the treatment of severe liver diseases, screening of drug toxicities, basic research of several hepatocytic disorders, and liver transplantation. Here we briefly summarize the growing number of potential applications of iPSCs for treatment of liver disease.
Twenty-eight years later: A case of superior vena cava aneurysm secondary to cystic hygroma
Haddad, Raad A., Jouni, Hayan, Geske, Jeffrey B. , Geske, Jeffrey B

Vascular Medicine | April 24, 2014 | Volume: 19 | Issue: 5 | Pages: 417-418

10.1177/1358863x14531640 | PMID 24760576 Get It

Editorial Commentary
Myers, Robert P.

Urology Practice | April 23, 2014 | Volume: 1 | Issue: 2 | Pages: 90-91

10.1016/j.urpr.2014.03.007 Get It

MRI With Spin Labeling for Diagnosis of Early Chronic Pancreatitis
Takahashi, Naoki , Chari, Suresh T. , Takahashi, Naoki , Chari, Suresh T

American Journal of Roentgenology | April 23, 2014 | Volume: 202 | Issue: 5 | Pages: 1035-1036

10.2214/ajr.14.12575 | PMID 24758656 Get It

Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity
Errington‐Mais, Fiona , Steele, Lynette P., Prestwich, Robin, Harrington, Kevin J. , Pandha, Hardev , Vidal, Laura , Bono, Johann S. de , Selby, Peter J. , Vile, Richard G. , Melcher, Alan , Coffey, Matt C. , Errington-Mais, Fiona , Melcher, Alan A , Harrington, Kevin , de Bono, Johann

The Journal of Immunology | April 23, 2014 | Volume: 180 | Issue: 9 | Pages: 6018-6026

10.4049/jimmunol.180.9.6018 | PMID 18424722 Get It

Abstract Oncolytic viruses can exert their antitumor activity via direct oncolysis or activation of antitumor immunity. Although reovirus is currently under clinical investigation for the treatment of localized or disseminated cancer, any potential immune contribution to its efficacy has not been addressed. This is the first study to investigate the ability of reovirus to activate human dendritic cells (DC), key regulators of both innate and adaptive immune responses. Reovirus induced DC maturation and stimulated the production of the proinflammatory cytokines IFN-α, TNF-α, IL-12p70, and IL-6. Activation of DC by reovirus was not dependent on viral replication, while cytokine production (but not phenotypic maturation) was inhibited by blockade of PKR and NF-κB signaling. Upon coculture with autologous NK cells, reovirus-activated DC up-regulated IFN-γ production and increased NK cytolytic activity. Moreover, short-term coculture of reovirus-activated DC with autologous T cells also enhanced T cell cytokine secretion (IL-2 and IFN-γ) and induced non-Ag restricted tumor cell killing. These data demonstrate for the first time that reovirus directly activates human DC and that reovirus-activated DC stimulate innate killing by not only NK cells, but also T cells, suggesting a novel potential role for T cells in oncolytic virus-induced local tumor cell death. Hence reovirus recognition by DC may trigger innate effector mechanisms to complement the virus’s direct cytotoxicity, potentially enhancing the efficacy of reovirus as a therapeutic agent.
Rare presentation of sebaceous hyperplasia
Lester, Rachael A, Torgerson, Rochelle R. , Sandhu, Nicole P. , Lester, Rachael

BMJ Case Reports | April 23, 2014 | Volume: 2014 | Issue: No issue available | Pages: bcr2014204025

10.1136/bcr-2014-204025 | PMID 24759166 Get It

A 23-year-old woman presented with an 8-month history of asymptomatic thickening of the central areola bilaterally and oily nipple discharge. On examination, there were yellowish-pink papules coalescing into plaques bilaterally. Biopsy showed ectopic sebaceous glands (Montgomery tubercles), known as bilateral areolar sebaceous hyperplasia.
Recent Advances in the Diagnosis and Management of Autoimmune Pancreatitis
Shanbhogue, Krishna , Takahashi, Naoki , Sandrasegaran, Kumaresan , Khandelwal, Ashish , Prasad, Srinivasa R. , Takahashi, Naoki

American Journal of Roentgenology | April 23, 2014 | Volume: 202 | Issue: 5 | Pages: 1007-1021

10.2214/ajr.13.11247 | PMID 24758653 Get It